More:    MJNA HOME        CANNABIS NEWS        SHOP        CONTACT 

  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
Bloomberg News Features Medical Marijuana, Inc. CEO Discussing Growth of CBD Market in Brazil

Bloomberg News Features Medical Marijuana, Inc. CEO Discussing Growth of CBD Market in Brazil

by adminAdrianRamirez | Apr 17, 2019 | HempMeds Brasil, Press Releases

SAN DIEGO, April 17, 2019 — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, today announced that it has garnered news coverage in international media outlet BloombergNews. An April 16, 2019 article entitled,...
Medical Marijuana, Inc. Subsidiary Phyto Animal Health Adds Skin Vitality to World’s Leading CBD Pet Product Line

Medical Marijuana, Inc. Subsidiary Phyto Animal Health Adds Skin Vitality to World’s Leading CBD Pet Product Line

by adminAdrianRamirez | Apr 16, 2019 | Press Releases

SAN DIEGO, April 16, 2019 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, subsidiary Phyto Animal Health today announced the launch of its newest cannabidiol (CBD) pet product, Skin Vitality. Skin...
Forbes, Fox Business, Benzinga, and the Motley Fool Feature Medical Marijuana, Inc. Headlines this Week

Forbes, Fox Business, Benzinga, and the Motley Fool Feature Medical Marijuana, Inc. Headlines this Week

by adminAdrianRamirez | Apr 12, 2019 | Media Coverage

The growing CBD market, cannabis stocks, CBD and athletes, and cannabinoid pharmaceuticals among the news from our portfolio of companies this week. Medical Marijuana, Inc. and our family of companies continued to make news this week as we work to innovate the CBD...
Medical Marijuana, Inc. Subsidiary Kannaway® Predicts Upcoming “Believe” National Convention to be Largest in Company History

Medical Marijuana, Inc. Subsidiary Kannaway® Predicts Upcoming “Believe” National Convention to be Largest in Company History

by adminAdrianRamirez | Apr 11, 2019 | Kannaway, Press Releases

SAN DIEGO, April 11, 2019 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, subsidiary Kannaway® announced today that is hosting its “Believe” National Convention from April 12-14 in San...
Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Enters Services Agreement with CRO to Begin Clinical Studies on Dronabinol and CBD Chewing Gums

Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Enters Services Agreement with CRO to Begin Clinical Studies on Dronabinol and CBD Chewing Gums

by adminAdrianRamirez | Apr 10, 2019 | Axim Biotechnologies, Press Releases

SAN DIEGO, April 10, 2019 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, announced that its investment company AXIM® Biotechnologies (“AXIM® Biotech” or “AXIM”) (OTCQB:AXIM), a...
« Older Entries
Next Entries »

Recent Posts

  • Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point
  • Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Major Features Across Several Marquee Brazilian Press Outlets
  • Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Participates in Research Finding Promising Therapeutic Benefits of CBD in Parkinson’s Disease Treatment

Recent Comments

No comments to show.

Home     Company    Education     Careers     Shop

This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

Food and Drug Administration (FDA) Disclosure

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Leaving Our Website Disclaimer: If we have a research link to a website where we sell products or have product information you are now leaving the medicalmarijuanainc.com website. Links to any informational websites are provided solely as a service to our users.

The link provides additional information that may be useful or interesting and has no aliation to the promotion, sale and distribution of Medical Marijuana Inc. products. The link does not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site.

* Cannabidiol (CBD) is a naturally-occurring constituent of the industrial hemp plant.

Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp based products.

© 2021 Medical Marijuana, Inc. All Rights Reserved.